Bright Minds Biosciences Stock Analysis

Bright Stock Analysis Notes

About 20.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.98. Bright Minds Biosciences had not issued any dividends in recent years. The entity had 1:5 split on the 14th of July 2023. Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States. To learn more about Bright Minds Biosciences call Ian McDonald at 647 865 8622 or check out https://brightmindsbio.com.

Bright Minds Biosciences Investment Alerts

Bright Minds Biosciences Upcoming and Recent Events

Bright Largest EPS Surprises

View All Earnings Estimates

Bright Minds Environmental, Social, and Governance (ESG) Scores

Bright Stock Institutional Investors

Note, although Bright Minds' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bright Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 496.2 M.

Bright Profitablity

Management Efficiency

Bright Minds Biosciences has return on total asset (ROA) of (0.1831) % which means that it has lost $0.1831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3079) %, meaning that it created substantial loss on money invested by shareholders. Bright Minds' management efficiency ratios could be used to measure how well Bright Minds manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.55. The current Return On Capital Employed is estimated to decrease to -0.61. At this time, Bright Minds' Total Assets are most likely to increase significantly in the upcoming years. The Bright Minds' current Total Current Assets is estimated to increase to about 8.4 M, while Net Tangible Assets are projected to decrease to roughly 8.4 M.

Technical Drivers

As of the 30th of November, Bright Minds shows the Risk Adjusted Performance of 0.123, downside deviation of 3.94, and Mean Deviation of 3.76. Bright Minds Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Bright Minds Biosciences information ratio, as well as the relationship between the potential upside and kurtosis to decide if Bright Minds Biosciences is priced correctly, providing market reflects its regular price of 70.0 per share. Given that Bright Minds has jensen alpha of 0.7204, we suggest you to validate Bright Minds Biosciences's prevailing market performance to make sure the company can sustain itself at a future point.

Bright Minds Biosciences Price Movement Analysis

Bright Minds Biosciences Insider Trading Activities

Bright Minds Outstanding Bonds

Bright Minds Predictive Daily Indicators

Bright Minds Corporate Filings

Bright Minds Forecast Models

Bright Minds' time-series forecasting models are one of many Bright Minds' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bright Minds' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bright Minds prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bright shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bright Minds. By using and applying Bright Stock analysis, traders can create a robust methodology for identifying Bright entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bright analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bright analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Bright Minds Biosciences stock analysis indicators help investors evaluate how Bright Minds stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bright Minds shares will generate the highest return on investment. By understating and applying Bright Minds stock analysis, traders can identify Bright Minds position entry and exit signals to maximize returns.

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.